Lipella Pharmaceuticals Inc. Profile Avatar - Palmy Investing

Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formula…

Biotechnology
US, Pittsburgh [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Lipella Pharmaceuticals Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Lipella Pharmaceuticals Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Lipella Pharmaceuticals Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of LIPO's Analysis
CIK: 1347242 CUSIP: 53630L100 ISIN: US53630L1008 LEI: - UEI: -
Secondary Listings
LIPO has no secondary listings inside our databases.